Singapore markets closed

Clearside Biomedical, Inc. (CLSD)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.1900-0.0400 (-3.25%)
At close: 04:00PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
8,452
8,226
1,327
29,575
7,894
-
Cost of revenue
-
355
204
0
0
-
Gross profit
-
7,871
1,123
29,575
7,894
-
Operating expenses
Research development
22,010
20,846
19,630
18,537
15,073
-
Selling general and administrative
11,535
11,869
11,770
11,665
10,756
-
Total operating expenses
33,545
32,715
31,400
30,202
25,829
-
Operating income or loss
-25,448
-24,844
-30,277
-627
-17,935
-
Interest expense
9,596
9,360
3,339
0
0
-
Total other income/expenses net
-
1,719
669
1,003
-275
-
Income before tax
-34,968
-32,485
-32,947
376
-18,210
-
Income from continuing operations
-34,968
-32,485
-32,947
376
-18,210
-
Net income
-34,968
-32,485
-32,947
376
-18,210
-
Net income available to common shareholders
-34,968
-32,485
-32,947
376
-18,210
-
Basic EPS
-0.61
-
-0.55
0.01
-0.39
-0.81
Diluted EPS
-0.61
-
-0.55
0.01
-0.39
-0.81
Basic average shares
61,308
-
60,205
58,492
46,507
38,171
Diluted average shares
61,308
-
60,205
59,907
46,507
38,171